DOTAREM (Guerbet LLC)
Welcome to the PulseAid listing for the DOTAREM drug offered from Guerbet LLC. This Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Guerbet LLC |
NON-PROPRIETARY NAME: | gadoterate meglumine |
SUBSTANCE NAME: | GADOTERATE MEGLUMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-03-20 |
END MARKETING DATE: | 0000-00-00 |
DOTAREM HUMAN PRESCRIPTION DRUG Details:
Item Description | DOTAREM from Guerbet LLC |
LABELER NAME: | Guerbet LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 376.9(mg/mL) |
START MARKETING DATE: | 2013-03-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67684-2000_c205ab10-1eda-46aa-8b40-6a1b8d83ec56 |
PRODUCT NDC: | 67684-2000 |
APPLICATION NUMBER: | NDA204781 |
Other GADOTERATE MEGLUMINE Pharmaceutical Manufacturers / Labelers: